Article Details
Retrieved on: 2022-11-30 10:46:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BioNTech (BNTX) and Ryvu Therapeutics signed a collaboration and license agreement for small molecule programs targeting immune modulation in ...
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here